Emerald Mutual Fund Advisers Trust United Therapeutics Corp Transaction History

Emerald Mutual Fund Advisers Trust

  • $1.45 Billion
  • Q4 2024

A detailed history of Emerald Mutual Fund Advisers Trust transactions in United Therapeutics Corp stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 2,702 shares of UTHR stock, worth $864,261. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,702
Previous 311 768.81%
Holding current value
$864,261
Previous $111,000 758.56%
% of portfolio
0.07%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$348.66 - $410.0 $833,646 - $980,310
2,391 Added 768.81%
2,702 $953,000
Q3 2024

Oct 29, 2024
BUY
$311.04 - $363.55 $96,733 - $113,064
311 New
311 $111,000
Q2 2023

Aug 10, 2023
SELL
$205.19 - $232.99 $11.4 Million - $12.9 Million
-55,402 Reduced 99.1%
501 $110,000
Q1 2023

May 04, 2023
SELL
$212.99 - $276.17 $2.54 Million - $3.3 Million
-11,935 Reduced 17.59%
55,903 $12.5 Million
Q4 2022

Feb 03, 2023
SELL
$205.95 - $280.43 $7.2 Million - $9.81 Million
-34,979 Reduced 34.02%
67,838 $18.9 Million
Q3 2022

Oct 25, 2022
SELL
$203.3 - $244.17 $6.27 Million - $7.53 Million
-30,846 Reduced 23.08%
102,817 $21.5 Million
Q2 2022

Jul 29, 2022
SELL
$174.81 - $241.14 $7.04 Million - $9.71 Million
-40,277 Reduced 23.16%
133,663 $31.5 Million
Q1 2022

Apr 29, 2022
SELL
$166.16 - $213.96 $2.67 Million - $3.44 Million
-16,083 Reduced 8.46%
173,940 $31.2 Million
Q4 2021

Feb 02, 2022
BUY
$184.32 - $216.08 $1.09 Million - $1.28 Million
5,940 Added 3.23%
190,023 $41.1 Million
Q3 2021

Oct 28, 2021
SELL
$179.86 - $214.88 $37,051 - $44,265
-206 Reduced 0.11%
184,083 $34 Million
Q2 2021

Jul 29, 2021
SELL
$170.47 - $211.93 $374,522 - $465,610
-2,197 Reduced 1.18%
184,289 $33.1 Million
Q1 2021

Apr 29, 2021
BUY
$153.94 - $174.85 $79,586 - $90,397
517 Added 0.28%
186,486 $31.2 Million
Q4 2020

Jan 29, 2021
BUY
$101.87 - $151.79 $1.21 Million - $1.81 Million
11,923 Added 6.85%
185,969 $28.2 Million
Q3 2020

Oct 28, 2020
BUY
$99.9 - $121.13 $20,879 - $25,316
209 Added 0.12%
174,046 $17.6 Million
Q2 2020

Jul 28, 2020
BUY
$92.74 - $125.82 $6.13 Million - $8.31 Million
66,084 Added 61.33%
173,837 $21 Million
Q1 2020

Apr 30, 2020
BUY
$79.39 - $115.35 $8.55 Million - $12.4 Million
107,753 New
107,753 $10.2 Million

Others Institutions Holding UTHR

# of Institutions
724
Shares Held
58.5M
Call Options Held
123K
Put Options Held
104K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Emerald Mutual Fund Advisers Trust Portfolio

Follow Emerald Mutual Fund Advisers Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email